使用JAK抑制剂巴瑞替尼有效治疗口腔扁平苔藓。 - Suppr

Suppr

超能文献

Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.

作者信息

Moussa Anthony, Colla Themis, Morrison Brendan, Sinclair Rodney

机构信息

Sinclair Dermatology, East Melbourne, Victoria, Australia.

Australian Clinical Labs, Traralgon, Victoria, Australia.

出版信息

Australas J Dermatol. 2022 May;63(2):276-277. doi: 10.1111/ajd.13811. Epub 2022 Feb 25.

DOI:10.1111/ajd.13811

PMID:35213737

Abstract

摘要

相似文献

Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.

Australas J Dermatol. 2022 May;63(2):276-277. doi: 10.1111/ajd.13811. Epub 2022 Feb 25.

Repigmentation of vitiligo with oral baricitinib.

Australas J Dermatol. 2020 Nov;61(4):374-376. doi: 10.1111/ajd.13348. Epub 2020 Jun 3.

Oral JAK inhibitor baricitinib effective in JIA.

Nat Rev Rheumatol. 2023 Sep;19(9):539. doi: 10.1038/s41584-023-01019-y.

The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

Biochem Pharmacol. 2021 Oct;192:114690. doi: 10.1016/j.bcp.2021.114690. Epub 2021 Jul 16.

Baricitinib: therapeutic potential for moderate to severe atopic dermatitis.

Expert Opin Investig Drugs. 2020 Oct;29(10):1089-1098. doi: 10.1080/13543784.2020.1800639. Epub 2020 Aug 14.

Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib.

Dermatol Ther. 2022 Sep;35(9):e15724. doi: 10.1111/dth.15724. Epub 2022 Jul 31.

Successful treatment of alopecia areata-associated trachyonychia with baricitinib.

Int J Dermatol. 2024 Aug;63(8):1089-1090. doi: 10.1111/ijd.17137. Epub 2024 Mar 21.

Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.

Clin Exp Dermatol. 2021 Oct;46(7):1330-1332. doi: 10.1111/ced.14712. Epub 2021 Jun 4.

Use of tofacitinib in baricitinib-refractory atopic dermatitis: An example of JAK inhibitor switching.

Pediatr Dermatol. 2024 Jan-Feb;41(1):139-140. doi: 10.1111/pde.15386. Epub 2023 Jul 26.

Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.

Platelets. 2022 Apr 3;33(3):404-415. doi: 10.1080/09537104.2021.1934665. Epub 2021 Jun 7.

引用本文的文献

Use of JAK Inhibitors in Lichen Planus: An Update.

Medicina (Kaunas). 2025 Jun 8;61(6):1056. doi: 10.3390/medicina61061056.

Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells.

J Clin Invest. 2024 Nov 14;135(2):e179436. doi: 10.1172/JCI179436.

Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.

Int J Mol Sci. 2024 Sep 8;25(17):9720. doi: 10.3390/ijms25179720.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

What can we learn from treatments of oral lichen planus?

Front Cell Infect Microbiol. 2024 Feb 15;14:1279220. doi: 10.3389/fcimb.2024.1279220. eCollection 2024.

Oral Lichen Planus: An Update on Diagnosis and Management.

Am J Clin Dermatol. 2024 Jan;25(1):35-53. doi: 10.1007/s40257-023-00814-3. Epub 2023 Sep 15.

Therapeutic strategies for oral lichen planus: State of the art and new insights.

Front Med (Lausanne). 2022 Oct 4;9:997190. doi: 10.3389/fmed.2022.997190. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.

Australas J Dermatol. 2022 May;63(2):276-277. doi: 10.1111/ajd.13811. Epub 2022 Feb 25.

Repigmentation of vitiligo with oral baricitinib.

Australas J Dermatol. 2020 Nov;61(4):374-376. doi: 10.1111/ajd.13348. Epub 2020 Jun 3.

Oral JAK inhibitor baricitinib effective in JIA.

Nat Rev Rheumatol. 2023 Sep;19(9):539. doi: 10.1038/s41584-023-01019-y.

The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

Biochem Pharmacol. 2021 Oct;192:114690. doi: 10.1016/j.bcp.2021.114690. Epub 2021 Jul 16.

Baricitinib: therapeutic potential for moderate to severe atopic dermatitis.

Expert Opin Investig Drugs. 2020 Oct;29(10):1089-1098. doi: 10.1080/13543784.2020.1800639. Epub 2020 Aug 14.

Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib.

Dermatol Ther. 2022 Sep;35(9):e15724. doi: 10.1111/dth.15724. Epub 2022 Jul 31.

Successful treatment of alopecia areata-associated trachyonychia with baricitinib.

Int J Dermatol. 2024 Aug;63(8):1089-1090. doi: 10.1111/ijd.17137. Epub 2024 Mar 21.

Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.

Clin Exp Dermatol. 2021 Oct;46(7):1330-1332. doi: 10.1111/ced.14712. Epub 2021 Jun 4.

Use of tofacitinib in baricitinib-refractory atopic dermatitis: An example of JAK inhibitor switching.

Pediatr Dermatol. 2024 Jan-Feb;41(1):139-140. doi: 10.1111/pde.15386. Epub 2023 Jul 26.

Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.

Platelets. 2022 Apr 3;33(3):404-415. doi: 10.1080/09537104.2021.1934665. Epub 2021 Jun 7.

引用本文的文献

Use of JAK Inhibitors in Lichen Planus: An Update.

Medicina (Kaunas). 2025 Jun 8;61(6):1056. doi: 10.3390/medicina61061056.

Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells.

J Clin Invest. 2024 Nov 14;135(2):e179436. doi: 10.1172/JCI179436.

Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.

Int J Mol Sci. 2024 Sep 8;25(17):9720. doi: 10.3390/ijms25179720.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

What can we learn from treatments of oral lichen planus?

Front Cell Infect Microbiol. 2024 Feb 15;14:1279220. doi: 10.3389/fcimb.2024.1279220. eCollection 2024.

Oral Lichen Planus: An Update on Diagnosis and Management.

Am J Clin Dermatol. 2024 Jan;25(1):35-53. doi: 10.1007/s40257-023-00814-3. Epub 2023 Sep 15.

Therapeutic strategies for oral lichen planus: State of the art and new insights.

Front Med (Lausanne). 2022 Oct 4;9:997190. doi: 10.3389/fmed.2022.997190. eCollection 2022.